RAF1 and neoplasm: By suppressing the activity of VGFR-2, VGFR-3, and RAF-1, it effectively hampers tumor cell proliferation through direct blockade of the RAF/MEK/ERK-mediated signaling pathway (Wilhelm et al., 2008; Gentile et al., 2016; Kim et al., 2018).